Biotechnology Lab Equipment, Machines, Servicing

Molecular Devices is at the forefront of advancing scientific discovery through innovative technologies that enhance cell culture and drug development processes. Their Organoid Innovation Center exemplifies this commitment by integrating state-of-the-art automated 3D imaging and cell culture systems. This facility allows researchers to scale complex 3D biological models, facilitating the development of organoids that closely mimic human tissues. By leveraging proprietary bioprocess technology, Molecular Devices produces reliable and predictive patient-derived organoids, which are essential for high-throughput screening and personalized medicine. Their automated workflows streamline the entire process from cell culture to imaging and data analysis, ensuring consistent and biologically relevant results.

In addition to organoid technology, Molecular Devices offers a range of automated solutions for high-throughput screening and cell line development. Their SpectraMax® microplate readers and SoftMax® Pro software are widely recognized in the industry for their ability to support GxP compliance and enhance laboratory efficiency. The introduction of the CellXpress.ai™ system further exemplifies their innovation, utilizing AI-driven automation to improve workflows and assay reliability. With a focus on 3D biology and lab automation, Molecular Devices empowers researchers to accelerate drug discovery and development, ultimately contributing to improved therapeutic outcomes and quality of life for patients worldwide.

United States

Molecular Devices

Molecular Devices

Company Details